C4 Therapeutics
CCCC
CCCC
120 hedge funds and large institutions have $117M invested in C4 Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.88% less ownership
Funds ownership: 80.09% → 76.21% (-3.9%)
49% less capital invested
Capital invested by funds: $229M → $117M (-$112M)
Holders
120
Holding in Top 10
–
Calls
$193K
Puts
$8K
Top Buyers
| 1 | +$3.92M | |
| 2 | +$1.81M | |
| 3 | +$1.04M | |
| 4 |
Renaissance Technologies
New York
|
+$922K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$793K |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$5.25M | |
| 3 | -$2.28M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.04M |
| 5 |
Rafferty Asset Management
New York
|
-$1.05M |